English
Back
Download
Log in to access Online Inquiry
Back to the Top
Rumble shares continue to surge: Time to follow crypto money?
Views 958K Contents 60

🟢 Watchlist MONDAY December 23,2024. ➡️N F A ! READ NOTE

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits. GREED will make losr and get trapped.
5. Always remember shorts include dark pools.
6. Most importantly, DON’T BLAME ME for your losses. I already give watchlist and stock education. The ball is on you. I give you “watchlist” which means its on watch for me, not an open position.
7. I DO NOT give buy or sell advice
8. CH (cash on hand); AH (after hours): RTH (regular trading hours)
9. No buy pressure/momentum- No day trade.
10. Always have a stop loss. Set REALISTIC price targets or profit targets. DO NOT listen to those who hype up a stock. Stick with fundamentals. Either they are bag holding, a part of pump and dump group.
11. Do NOT be a blind follower. We are all gifted with intelligence- USE IT.
12. Don’t bring your toxicity in the trading platform. We are a community supposed to help each other.
In alphabetical order:
$Air Industries Group (AIRI.US)$ PR 12/20: Secures Long-term Contract Valued At More Than $33M To Manufacture, Supply Complex Components For CH-53K King Stallion Helicopter Program. May have delayed market reaction. Low float. $170K. High risk for dilution.

$Actelis Networks (ASNS.US)$ PR 12/20: Launches MetaShield, AI-Based Cybersecurity Solution To Drive SaaS Growth And Edge Infrastructure Resilience. Low float. COH $800K good for 1.5 months.

$BioAge Labs (BIOA.US)$ PRs 2 consecutive days: 12/19 Global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program where BioArctic will receive a USD 100 million upfront payment and up to USD 1.25 billion in milestone payments: 12/18: Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions; Novartis To Pay Up To $20M Comprising Upfront Payments And Research Funding; BioAge May Receive Up To $530M In Future Long-Term Research, Development, And Commercial Milestones. Hasn’t gained much traction. This for me is just waiting to rally. Low float. No dilution history. Caution. For me, the market hasn’t digested much of these news, overshadowed by a lot of runners.
$Brera Holdings (BREA.US)$ No PR. Chart shows consolidation where 10/20 EMA closely aligned with price. Breakout at 0.75 will signal bullish reversal. No cash. High risk for dilution. Dont linger playing this if it runs.
$Heritage Distilling (CASK.US)$ PR 12/19: Two key appointments to its executive leadership and Board of Directors including Troy Alstead, former COO of Starbucks Corporation. Up AH. COH $10.1M good for 27.1 months

$Cheetah Net Supply Chain Service (CTNT.US)$ PR 8K filed 12/20: Completed acquisition of TW & EW services. Low float stock. CTB 203%.

$Cyngn (CYN.US)$ PR 12/29: Made a follow up offering with price of common share offered at $1.61/share. Price currently at 0.5090, way below the offered price: May rebound. Low float. CTB 429%. COH $20.4M good for 11.8 months

$Edible Garden (EDBL.US)$ PR 12/20: Preliminary Sales Results During Key Thanksgiving Time Period Surge 51% in 2024. Low float. No COH. High risk for dilution.

$PMGC Holdings (ELAB.US)$ PR 12/20: Ticker change Monday. PMGC. Low float. 0 shares LTB. COH $5.3M good for 13.8 months
$Freight Technologies (FRGT.US)$ No PR. Up after hours, price crossing VWAP. Price is above 10/20/50/100/200 EMA- bullish short and medium term. Microfloat. SI 32.67%. No COH. High risk dilution.

$Gorilla Technology (GRRR.US)$ PR 12/17: $2B pipeline, enters 2025 with $93M backlog, expects revenue $90-100M. Still awaiting formal PR of its $438M project in SE Asia. Technicals: Trading above 20/50/100 EMA- bullish. MACD also above signal line - bullish. For me, this can be a good day trade (if it gets buy pressure) and swing. COH $22.7M good for 12.1 months.
$Humacyte (HUMA.US)$ PR 12/19: FDA granted full approval for SYMVESS™ (acellular tissue engineered vessel-tyod) which authorizes its use in adults as a vascular conduit for extremity arterial injuries requiring urgent revascularization to prevent imminent limb loss. SI 21.27%. COH $91.8M good for 11.6 months. Received but rating.
$New Horizon Aircraft (HOVR.US)$ PR 12/20 AH: Secures $8.4 Million Strategic Investment. Low float. COH $9.7M good for 19.6 months.

$Homestolife (HTLM.US)$ No PR but up AH. Price crossed VWAP. Singapore company. Either upcoming PR or just pure pump. Low float . COH $4.3M good for 28.8 months.

$JIADE (JDZG.US)$ PR 12/20: Received a notification from Nasdaq on December 17, 2024, indicating non-compliance with the minimum bid price requirement. Given until June 16,2025 to comply. It may be an extension pump. Low float China stock. COH $2.61M

$KULR Technology (KULR.US)$ last PR 12/18 Regained listing compliance. Technical analysis: Trading above 20/50/200 EMA suggesting bullish trend. COH $13.2M good for 9.5 months.
$SEALSQ Corp (LAES.US)$ 12/20: Reported the integration of its latest post-quantum
cryptographic chips on WISeSat satellites; 12/19: Just completed $25M offering. Proceeds will be used to fund the deployment of its next generation post-quantum semiconductor technology and ASIC capabilities; 12/17: announced a partnership with Hedera to deliver next-generation quantum-resistant semiconductors. Technicals: Trading above 5/20 EMA- bullish. SI 14.22%. COH $66.8M good for 37.1 months. Add $WISeKey (WKEY.US)$ because LAES is subsidiary of WKEY.
$Snow Lake Resources (LITM.US)$ PR 12/20: Completed a US$6.45 million public offering, securing funding for its 2025 exploration programs for lithium and uranium. Good stuff. 0 shares LTB.

$Lottery.com (LTRY.US)$ PR AH 12/20: Regained compliance with Nasdaq's listing rules after filing its Q3 2024 Form 10-Q. COH $320K. Low float. High risk for dilution.

$Intuitive Machines (LUNR.US)$ PR after AH 12/20: Multiple 13Ds with one with 42.2M aggregate shares beneficially owned by the individual equivalent to 35.4% (read announcement tab). SI 19.87%. COH 167.6M good for 27.1 months

$Nukkleus (NUKK.US)$ 12/17 Executed a controlling stake ($26M value) in Iron Dome supplier. Technicals: still bullish trading above 20/50/200 during RTH. After hours Friday is not realistic gauge. 0 shares LTB. COH $11.4M good for 39.2 months.

$Nvni Group (NVNI.US)$ No PR. Been running for 2 days , it’s a speculative play based on delisting news. History: Received staff determination letter on Nov 12.2024 due to non compliance with listing requirement of timely filing of Form 20-F. NVNI filed appeal Nov 15 which automatically stays suspension for 15 days (until Nov 30). The company also intended to request an extended stay while appeal is in process. Low float. May still rock tomorrow. 0 shares LTB. COH $0.7M. High risk for dilution. Take note 57% of shares traded Friday were diverted to dark pool.

$Onfolio (ONFO.US)$ PR AH 12/20: Announced quarterly preferred stock cash dividend $0.75/share. This type of news can be attractive to investors. This will be a momentum play if it goes up again Monday.

$Phio Pharmaceuticals (PHIO.US)$ Near 52 week low. Possible bottom play. Low float. 0 shares LTB. COH $4.7M good for 7.4 months.

$QuantumScape (QS.US)$ Almost 52 week low. SI 17.52%. No dilution risk

$Quantum-Si (QSI.US)$ PR 12/20: New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™. COH $176.4M good for 24.5 months

$Rumble (RUM.US)$ PR 12/20 AH: Secured a $775 million strategic investment from Tether ($USDT), the largest digital assets company and stablecoin provider. Transaction allocates $250 million for growth initiatives, with the remaining funds dedicated to a self tender offer for up to 70 million shares of Rumble's Class A Common Stock at $7.50 per share. SI 18.55% COH $109M
$Rezolve AI (RZLV.US)$ Bullish. Price above 10/20 MA, currently oversold. Caution though as this has prospectus to sell common shares from time to time

$Samfine Creation Holdings (SFHG.US)$ PR AH 12/20: Good ER: Revenue up 61.3% YoY, Net income HK$0.8M vs net loss off HK$3.8M YoY. China low float stock. COH $9.6M

$Safe Pro Group (SPAI.US)$ PR 12/20: Good ER Record-breaking annual revenue growth exceeding 130% for fiscal 2024, Fourth quarter revenue increase of over 200% year-over-year. Low float. CTB 338%. Previous PR last week featured by NATO. COH $1.4M good for 4.1 months

$Tivic Health Systems (TIVC.US)$ Possible Bottom play. Low float. COH $1.7M good for 3.5 months.

$Tonix Pharmaceuticals (TNXP.US)$ Basis: Current Price is below 50 and 200 EMA but price approaching 10-day EMA suggesting SHORT term bullish momentum. PR 12/17: FDA accepted NDA for treatment of fibromyalgia. COH $19.3M good for 3.8 months. Low float.

$Trinity Biotech (TRIB.US)$ Possible Bottom Play. Relatively low float. COH $11.5M good for 31.3 months

$Virax Biolabs (VRAX.US)$ PR 12/21 BBC News UK: Poultry to be kept indoors amid rise in bird flu. This stock is based in UK

$Vivos Therapeutics (VVOS.US)$ PR 12/20 13G 9.9% disclosed on Dec 17.

$YY Group (YYGH.US)$ PR 12/20: YY Smart Tech Expands Strategic Partnerships to Drive Digital Transformation Across Asia valued at. $5M spanning 3 years. SG company.

*********
**********************************
Other stocks i continue monitoring:
$Davis Commodities (DTCK.US)$
$Lipella Pharmaceuticals (LIPO.US)$
$Tempest Therapeutics (TPST.US)$
*******************************************

Reverse Split
12/23 $iCoreConnect (ICCT.US)$ post RS float 1.1M shares
12/24 $Canoo (GOEV.US)$ post RS float 4.9M
********************************************
Delisting Stocks for possible Pre-Delisting pump.
Last trading day:
$Molecular Templates (MTEM.US)$ December 24 (Tuesday)
$American Lithium (AMLI.US)$ December 27
(Friday)
$Wilhelmina International (WHLM.US)$ December 31 (Tuesday)

*******************************************
Bird Flu Stocks
$Aethlon Medical (AEMD.US)$ COH
$5.2M good for 7.9 months. Low float

$BioCryst Pharmaceuticals (BCRX.US)$ No dilution risk. Up AH

$CureVac (CVAC.US)$ No dilution risk

$GeoVax Labs (GOVX.US)$ COH
$4.8M good for 2.6 months. Low float.
Up AH

$Inovio Pharmaceuticals (INO.US)$ COH $90.9M good for 9.7 months

$Nanoviricides (NNVC.US)$ COH
$1.6M good for 1.8 months. High dilution risk. Low float.

$China SXT Pharmaceuticals (SXTC.US)$ COH $11.4M. China low float.

$Virax Biolabs (VRAX.US)$ already above list
*******************************************
EDUCATION
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
44
93
4
1
1
+0
39
Translate
Report
685K Views
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
9498
Followers
55
Following
115K
Visitors
Follow